Search Results 131-140 of 21201 for Inhibition

  1. CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors - Mayo Clinic

    CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors · Share ...

  2. Beta blockers - Mayo Clinic

    Angiotensin-converting enzyme (ACE) inhibitors · Anxiety: A cause of high blood pressure? Arteriosclerosis / atherosclerosis · Artificial sweeteners: Any effect ...

  3. Publications - Sandra M. Herrmann, M.D. - Mayo Clinic

    Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy. ... Association of Proton Pump Inhibitor ...

  4. A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS) - Mayo Clinic

    Clinical Trials · A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS).

  5. Christina A. von Roemeling1, Laura Marlow1, Robert C. Smallridge2, John A. Copland1

    • Inhibition of SCD1 activity has been shown to induce the ER stress ... (A) Proposed model of SCD1 inhibitor and proteosome inhibitor drug synergy.

  6. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer · Share · Facebook · Twitter.

  7. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol) - Mayo Clinic

    This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studies how well a combination of different biomarker/ALK inhibitors work in treating ...

  8. A Study Of Gallium-68-labeled Fibroblast Activation Protein Inhibitor-46 (68Ga-FAPI-46) PET In Crohn’s Disease Patients - Mayo Clinic

    A Study Of Gallium-68-labeled Fibroblast Activation Protein Inhibitor-46 (68Ga-FAPI-46) PET In Crohn's Disease Patients · More about research at Mayo Clinic.

  9. A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors (GIST) - Mayo Clinic

    A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors (GIST) · Overview.

  10. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    About this study. The purpose of this trial is to test whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) ...